Agilent Technologies

A · Health Care · Market cap $39.1B

Q2 FY26 Apr 30, 2026 reported Jun 1, 2026

Revenue$1.8B +10% year over year

Gross profit$1B

Operating profit$0.4B

Net profit$0.3B 18% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Apr 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.8	100%	+10%
Non Instrumentation and Other	1.2	67%	+9%
Instrumentation	0.6	33%	+12%
Cost of revenue	−0.8	44%
Gross profit	1	54% margin	+2pp
Research & development	−0.1	7%	+0pp
SG&A	−0.5	25%	−2pp
Operating profit	0.4	22% margin	+4pp
Tax	−0.1
Net profit	0.3	18%	+6pp

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Jan 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.8	100%	+7%
Non Instrumentation and Other	1.1	61%	+8%
Instrumentation	0.7	39%	+5%
Cost of revenue	−0.9	50%
Gross profit	0.9	53% margin	−1pp
Research & development	−0.1	7%	+0pp
SG&A	−0.5	26%	+2pp
Operating profit	0.4	20% margin	−3pp
Tax	−0.1
Net profit	0.3	17%	−2pp

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Oct 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.9	100%	+9%
Non Instrumentation and Other	1.2	63%	+12%
Instrumentation	0.7	37%	+5%
Cost of revenue	−0.9	47%
Gross profit	1	53% margin	−1pp
Research & development	−0.1	6%	+0pp
SG&A	−0.4	23%	+0pp
Operating profit	0.4	24% margin	+0pp
Net profit	0.4	23%	+3pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Jul 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.7	100%	+10%
Non Instrumentation and Other	1.1	65%	+11%
Instrumentation	0.6	35%	+8%
Cost of revenue	−0.9	53%
Gross profit	0.9	51% margin	−3pp
Research & development	−0.1	6%	−2pp
SG&A	−0.4	24%	−1pp
Operating profit	0.4	21% margin	+0pp
Net profit	0.3	19%	+1pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26	Apr 30, 2026	Jun 1, 2026	$1.8B	+10%	22%	$0.3B	18%
Q1 FY26	Nov 1, 2025 – Jan 31, 2026	Mar 3, 2026	$1.8B	+7%	22%	$0.3B	17%
Q4 FY25	Aug 1 – Oct 31, 2025	Dec 22, 2025	$1.9B	+9%	21%	$0.4B	23%
Q3 FY25	May 1 – Jul 31, 2025	Aug 29, 2025	$1.7B	+10%	24%	$0.3B	19%